SEARCH

SEARCH BY CITATION

References

  • Aguero ME, Aron L, DeLuca AG, Timmis KN & Cabello FC (1984) A plasmid-encoded outer membrane protein, TraT, enhances resistance of Escherichia coli to phagocytosis. Infect Immun 46: 740746.
  • Barondess JJ & Beckwith J (1995) bor gene of phage lambda, involved in serum resistance, encodes a widely conserved outer membrane lipoprotein. J Bacteriol 177: 12471253.
  • Bhakdi S, Kuller G, Muhly M, Fromm S, Seibert G & Parrisius J (1987) Formation of transmural complement pores in serum-sensitive Escherichia coli. Infect Immun 55: 206210.
  • Binns MM, Mayden J & Levine RP (1982) Further characterization of complement resistance conferred on Escherichia coli by the plasmid genes traT of R100 and iss of ColV, I-K94. Infect Immun 35: 654659.
  • Bowdish DM, Davidson DJ & Hancock RE (2005) A re-evaluation of the role of host defence peptides in mammalian immunity. Curr Protein Pept Sci 6: 3551.
  • Buckles EL, Wang X, Lane MC et al. (2009) Role of the K2 capsule in Escherichia coli urinary tract infection and serum resistance. J Infect Dis 199: 16891697.
  • Bugla-Ploskonska G, Kiersnowski A, Futoma-Koloch B & Doroszkiewicz W (2009) Killing of Gram-negative bacteria with normal human serum and normal bovine serum: use of lysozyme and complement proteins in the death of Salmonella strains O48. Microb Ecol 58: 276289.
  • Burns SM & Hull SI (1998) Comparison of loss of serum resistance by defined lipopolysaccharide mutants and an acapsular mutant of uropathogenic Escherichia coli O75:K5. Infect Immun 66: 42444253.
  • Bury-Mone S, Nomane Y, Reymond N et al. (2009) Global analysis of extracytoplasmic stress signaling in Escherichia coli. PLoS Genet 5: e1000651.
  • Callewaert L & Michiels CW (2010) Lysozymes in the animal kingdom. J Biosci 35: 127160.
  • Clarke DJ (2010) The Rcs phosphorelay: more than just a two-component pathway. Future Microbiol 5: 11731184.
  • Dankert JR (1989) Complement-mediated inhibition of function in complement-resistant Escherichia coli. J Immunol 142: 15911595.
  • Dankert JR & Esser AF (1986) Complement-mediated killing of Escherichia coli: dissipation of membrane potential by a C9-derived peptide. Biochemistry 25: 10941100.
  • Degousee N, Kelvin DJ, Geisslinger G et al. (2011) Group V phospholipase A2 in bone marrow-derived myeloid cells and bronchial epithelial cells promotes bacterial clearance after Escherichia coli pneumonia. J Biol Chem 286: 3565035662.
  • Dennis EA, Cao J, Hsu YH, Magrioti V & Kokotos G (2011) Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev 111: 61306185.
  • Donaldson DM, Roberts RR, Larsen HS & Tew JG (1974) Interrelationship between serum beta-lysin, lysozyme, and the antibody-complement system in killing Escherichia coli. Infect Immun 10: 657666.
  • Elsbach P (1998) The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense. J Leukoc Biol 64: 1418.
  • Gaspar JA, Thomas JA, Marolda CL & Valvano MA (2000) Surface expression of O-specific lipopolysaccharide in Escherichia coli requires the function of the TolA protein. Mol Microbiol 38: 262275.
  • Goller CC & Seed PC (2010) High-throughput identification of chemical inhibitors of E. coli Group 2 capsule biogenesis as anti-virulence agents. PLoS One 5: e11642.
  • Grozdanov L, Zahringer U, Blum-Oehler G et al. (2002) A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917. J Bacteriol 184: 59125925.
  • Hancock RE & Scott MG (2000) The role of antimicrobial peptides in animal defenses. P Natl Acad Sci USA 97: 88568861.
  • Jacobson SH, Ostenson CG, Tullus K & Brauner A (1992) Serum resistance in Escherichia coli strains causing acute pyelonephritis and bacteraemia. APMIS 100: 147153.
  • Johnson JR (1991) Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 4: 80128.
  • Johnson TJ, Wannemuehler YM & Nolan LK (2008) Evolution of the iss gene in Escherichia coli. Appl Environ Microbiol 74: 23602369.
  • Lamarche MG, Dozois CM, Daigle F, Caza M, Curtiss R 3rd, Dubreuil JD & Harel J (2005) Inactivation of the pst system reduces the virulence of an avian pathogenic Escherichia coli O78 strain. Infect Immun 73: 41384145.
  • Levy O (2000) Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents. Blood 96: 26642672.
  • Levy O, Ooi CE, Weiss J, Lehrer RI & Elsbach P (1994) Individual and synergistic effects of rabbit granulocyte proteins on Escherichia coli. J Clin Invest 94: 672682.
  • Leying H, Suerbaum S, Kroll HP, Stahl D & Opferkuch W (1990) The capsular polysaccharide is a major determinant of serum resistance in K-1-positive blood culture isolates of Escherichia coli. Infect Immun 58: 222227.
  • Li G, Laturnus C, Ewers C & Wieler LH (2005) Identification of genes required for avian Escherichia coli septicemia by signature-tagged mutagenesis. Infect Immun 73: 28182827.
  • Liu YF, Yan JJ, Lei HY, Teng CH, Wang MC, Tseng CC & Wu JJ (2012) Loss of outer membrane protein C in Escherichia coli contributes to both antibiotic resistance and escaping antibody-dependent bactericidal activity. Infect Immun 80: 18151822.
  • Lloubes R, Cascales E, Walburger A, Bouveret E, Lazdunski C, Bernadac A & Journet L (2001) The Tol-Pal proteins of the Escherichia coli cell envelope: an energized system required for outer membrane integrity? Res Microbiol 152: 523529.
  • Maisetta G, Di Luca M, Esin S et al. (2008) Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3. Peptides 29: 16.
  • Maruvada R & Kim KS (2011) Extracellular loops of the Eschericia coli outer membrane protein A contribute to the pathogenesis of meningitis. J Infect Dis 203: 131140.
  • Marx G & Reinhart K (2008) Urosepsis: from the intensive care viewpoint. Int J Antimicrob Agents 31(suppl 1): S79S84.
  • Miajlovic H, Cooke NM, Moran GP, Rogers TR & Smith SG (2014) Response of extraintestinal pathogenic Escherichia coli to human serum reveals a protective role for Rcs-regulated exopolysaccharide colanic acid. Infect Immun 82: 298305.
  • Mittal R, Krishnan S, Gonzalez-Gomez I & Prasadarao NV (2011) Deciphering the roles of outer membrane protein A extracellular loops in the pathogenesis of Escherichia coli K1 meningitis. J Biol Chem 286: 21832193.
  • Noah JW, Ananthan S, Evans CW et al. (2010a) 3-(2,6-difluorobenzamido)-5-(4-ethoxyphenyl) thiophene-2-carboxylic acid inhibits. E. coli UT189 bacterial capsule biogenesis. Probe Reports from the NIH Molecular Libraries Program, Bethesda, MD.
  • Noah JW, Ananthan S, Evans CW et al. (2010b) N-(pyridin-4-yl)benzo[d]thiazole-6-carboxamide inhibits E. coli UT189 bacterial capsule biogenesis. Probe Reports from the NIH Molecular Libraries Program, Bethesda, MD.
  • O'Hara AM, Moran AP, Wurzner R & Orren A (2001) Complement-mediated lipopolysaccharide release and outer membrane damage in Escherichia coli J5: requirement for C9. Immunology 102: 365372.
  • Opal S, Cross A & Gemski P (1982) K antigen and serum sensitivity of rough Escherichia coli. Infect Immun 37: 956960.
  • Phan MD, Peters KM, Sarkar S et al. (2013) The serum resistome of a globally disseminated multidrug resistant uropathogenic clone. PLoS Genet 9: e1003834.
  • Pramoonjago P, Kaneko M, Kinoshita T et al. (1992) Role of TraT protein, an anticomplementary protein produced in Escherichia coli by R100 factor, in serum resistance. J Immunol 148: 827836.
  • Prasadarao NV, Blom AM, Villoutreix BO & Linsangan LC (2002) A novel interaction of outer membrane protein A with C4b binding protein mediates serum resistance of Escherichia coli K1. J Immunol 169: 63526360.
  • Rautemaa R, Jarvis GA, Marnila P & Meri S (1998) Acquired resistance of Escherichia coli to complement lysis by binding of glycophosphoinositol-anchored protectin (CD59). Infect Immun 66: 19281933.
  • Rhodius VA, Suh WC, Nonaka G, West J & Gross CA (2006) Conserved and variable functions of the sigmaE stress response in related genomes. PLoS Biol 4: e2.
  • Rittirsch D, Flierl MA & Ward PA (2008) Harmful molecular mechanisms in sepsis. Nat Rev Immunol 8: 776787.
  • Russo TA & Johnson JR (2003) Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect 5: 449456.
  • Russo TA, Moffitt MC, Hammer CH & Frank MM (1993) TnphoA-mediated disruption of K54 capsular polysaccharide genes in Escherichia coli confers serum sensitivity. Infect Immun 61: 35783582.
  • Sansano M Jr, Reynard AM & Cunningham RK (1985) Inhibition of serum bactericidal reaction by lipopolysaccharide. Infect Immun 48: 759762.
  • Sarma JV & Ward PA (2011) The complement system. Cell Tissue Res 343: 227235.
  • Schneider G, Dobrindt U, Bruggemann H et al. (2004) The pathogenicity island-associated K15 capsule determinant exhibits a novel genetic structure and correlates with virulence in uropathogenic Escherichia coli strain 536. Infect Immun 72: 59936001.
  • Siegfried L, Puzova H, Kmetova M & Kerestesova A (1992) Killing of alpha-haemolytic and non-haemolytic Escherichia coli strains in human serum and polymorphonuclear leucocytes. J Med Microbiol 37: 37.
  • Smith SG, Mahon V, Lambert MA & Fagan RP (2007) A molecular Swiss army knife: OmpA structure, function and expression. FEMS Microbiol Lett 273: 111.
  • Snyder JA, Haugen BJ, Buckles EL et al. (2004) Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun 72: 63736381.
  • Subashchandrabose S, Smith SN, Spurbeck RR, Kole MM & Mobley HL (2013) Genome-wide detection of fitness genes in uropathogenic Escherichia coli during systemic infection. PLoS Pathog 9: e1003788.
  • Sukupolvi S & O'Connor D (1987) Amino acid alterations in a hydrophobic region of the TraT protein of R6-5 increase the outer membrane permeability of enteric bacteria. Mol Gen Genet 210: 178180.
  • Taylor PW & Kroll HP (1984) Interaction of human complement proteins with serum-sensitive and serum-resistant strains of Escherichia coli. Mol Immunol 21: 609620.
  • Taylor PW & Robinson MK (1980) Determinants that increase the serum resistance of Escherichia coli. Infect Immun 29: 278280.
  • Tseng YT, Wang SW, Kim KS et al. (2012) NlpI facilitates deposition of C4 bp on Escherichia coli by blocking classical complement-mediated killing, which results in high-level bacteremia. Infect Immun 80: 36693678.
  • Ulett GC, Totsika M, Schaale K, Carey AJ, Sweet MJ & Schembri MA (2013) Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection. Curr Opin Microbiol 16: 100107.
  • Vanderkelen L, Ons E, Van Herreweghe JM, Callewaert L, Goddeeris BM & Michiels CW (2012) Role of lysozyme inhibitors in the virulence of avian pathogenic Escherichia coli. PLoS One 7: e45954.
  • Vogt SL & Raivio TL (2012) Just scratching the surface: an expanding view of the Cpx envelope stress response. FEMS Microbiol Lett 326: 211.
  • Wang CY, Wang SW, Huang WC et al. (2012) Prc contributes to Escherichia coli evasion of classical complement-mediated serum killing. Infect Immun 80: 33993409.
  • Weiser JN & Gotschlich EC (1991) Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1. Infect Immun 59: 22522258.
  • Whitfield C (2006) Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu Rev Biochem 75: 3968.
  • Wooster DG, Maruvada R, Blom AM & Prasadarao NV (2006) Logarithmic phase Escherichia coli K1 efficiently avoids serum killing by promoting C4bp-mediated C3b and C4b degradation. Immunology 117: 482493.